S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior

European Neuropsychopharmacology

Volumn 25, Issue 12, 2015, Pages 2372-2380

  Stroth, Nikolas ^a   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Behavior; Cyclic AMP; Depression; Frontal cortex; S100B; Serotonin 5 HT7 receptor

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; CYCLIC AMP; PROTEIN S100B; SEROTONIN 7 RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; FORSKOLIN; S100B PROTEIN, MOUSE; SEROTONIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIM TEST; FRONTAL CORTEX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; TRANSGENIC MOUSE; ANIMAL; BRAIN; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METABOLISM; MOLECULAR MODEL; NEWBORN; PSYCHOLOGY; SWIMMING;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLFORSIN; CYCLIC AMP; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, MOLECULAR; NEUROTRANSMITTER AGENTS; RECEPTORS, SEROTONIN; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SWIMMING;

EID: 84952637927     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.10.003     Document Type: Article

References (36)

1. 7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology 2009, 205:119-128.
2. Arolt V., Peters M., Erfurth A., Wiesmann M., Missler U., Rudolf S., Kirchner H., Rothermundt M. S100B and response to treatment in major depression: a pilot study. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2003, 13:235-239.
3. Baudry A., Mouillet-Richard S., Schneider B., Launay J.M., Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329:1537-1541.
4. Bendotti C., Cole S.E., Gobbi M., Hohmann C., Reeves R.H. Overexpression of S100beta in transgenic mice does not protect from serotonergic denervation induced by 5,7-dihydroxytryptamine. J. Neurosci. Res. 2002, 67:501-510.
5. Benton C.S., Miller B.H., Skwerer S., Suzuki O., Schultz L.E., Cameron M.D., Marron J.S., Pletcher M.T., Wiltshire T. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology 2012, 221:297-315.
6. 7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 2009, 141:239-247.
7. Cates L.N., Roberts A.J., Huitron-Resendiz S., Hedlund P.B. Effects of lurasidone in behavioral models of depression. Role of the 5-HT(7) receptor subtype. Neuropharmacology 2013, 70:211-217.
8. Clark R.A., Shoaib M., Hewitt K.N., Stanford S.C., Bate S.T. A comparison of InVivoStat with other statistical software packages for analysis of data generated from animal experiments. J. Psychopharmacol. 2012, 26:1136-1142.
9. Dempsey B.R., Shaw G.S. Identification of calcium-independent and calcium-enhanced binding between S100B and the dopamine D2 receptor. Biochemistry 2011, 50:9056-9065.
10. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I. S100B[U+05F3]s double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 2009, 1793:1008-1022.
11. Fano G., Fulle S., Della Torre G., Giambanco I., Aisa M.C., Donato R., Calissano P. S-100b protein regulates the activity of skeletal muscle adenylate cyclase in vitro. FEBS Lett. 1988, 240:177-180.
12. Fulle S., Mariggio M.A., Fano G., Salvatore A.M., Mercanti D., Petrelli C., Calissano P. Activation of brain adenylate-cyclase by S-100 protein via a possible interaction with G-protein(s). Neurosci. Res. Commun. 1992, 10:35-43.
13. Guilloux J.P., Mendez-David I., Pehrson A., Guiard B.P., Reperant C., Orvoen S., Gardier A.M., Hen R., Ebert B., Miller S., Sanchez C., David D.J. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology 2013, 73:147-159.
14. 7 receptor and disorders of the nervous system: an overview. Psychopharmacology 2009, 206:345-354.
15. 7 receptor inhibition and inactivation induce antidepressant-like behavior and sleep pattern. Biol. Psychiatry 2005, 58:831-837.
16. Hirst W.D., Price G.W., Rattray M., Wilkin G.P. Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes. Br. J. Pharmacol. 1997, 120:509-515.
17. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71:533-554.
18. Ivanenkov V.V., Jamieson G.A., Gruenstein E., Dimlich R.V. Characterization of S-100b binding epitopes. Identification of a novel target, the actin capping protein, CapZ. J. Biol. Chem. 1995, 270:14651-14658.
19. Kamei J., Miyata S., Sunohara T., Kamei A., Shimada M., Ohsawa M. Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test. J. Pharmacol. Sci. 2008, 108:381-384.
20. La Bella V., Ho B.K., Appel S.H. The differential in vitro stimulation of 3[U+05F3],5[U+05F3]-cyclic nucleotide phosphodiesterase by calcium binding proteins. Biochem. Mol. Biol. Int. 1997, 43:1195-1205.
21. 2 receptor function. Mol. Pharmacol. 2008, 74:371-378.
22. Marin P., Becamel C., Dumuis A., Bockaert J. 5-HT receptor-associated protein networks: new targets for drug discovery in psychiatric disorders?. Curr. Drug Targets 2012, 13:28-52.
23. 7 receptor in the central nervous system: from current status to future perspectives. Mol. Neurobiol. 2011, 43:228-253.
24. McClintock K.A., Shaw G.S. A logical sequence search for S100B target proteins. Protein Sci.: Publ. Protein Soc. 2000, 9:2043-2046.
25. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
26. 7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2011, 36:1275-1288.
27. Ramos B.P., Birnbaum S.G., Lindenmayer I., Newton S.S., Duman R.S., Arnsten A.F. Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron 2003, 40:835-845.
28. Reeves R.H., Yao J., Crowley M.R., Buck S., Zhang X., Yarowsky P., Gearhart J.D., Hilt D.C. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. USA 1994, 91:5359-5363.
29. Shimizu M., Nishida A., Zensho H., Yamawaki S. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes. J. Pharmacol. Exp. Ther. 1996, 279:1551-1558.
30. Soderberg O., Gullberg M., Jarvius M., Ridderstrale K., Leuchowius K.J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.G., Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 2006, 3:995-1000.
31. Soderberg O., Leuchowius K.J., Gullberg M., Jarvius M., Weibrecht I., Larsson L.G., Landegren U. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 2008, 45:227-232.
32. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., Vaugeois J.M., Nomikos G.G., Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006, 311:77-80.
33. Svenningsson P., Kim Y., Warner-Schmidt J., Oh Y.S., Greengard P. p11 and its role in depression and therapeutic responses to antidepressants. Nat. Rev. Neurosci. 2013, 14:673-680.
34. 4 receptor stimulation. J. Neurosci.: Off. J. Soc. Neurosci. 2009, 29:1937-1946.
35. 7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 2006, 51:578-586.
36. Zhang H.T. Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr. Pharm. Des. 2009, 15:1688-1698.